Remarkably, it has been demonstrated that a fraction of monocytes and NK cells, which express the fractalkine receptor CX3CR1+, are diminished in peripheral blood of HUS patients when compared to healthy donors. This evidence concerns the gene CX3CR1 and hemolytic-uremic syndrome.